• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生产和稳定三聚体流感血凝素茎域,用于具有潜在广泛保护作用的流感疫苗。

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.

机构信息

Departments of Chemical Engineering and Bioengineering, Stanford University, Stanford, CA 94305.

出版信息

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30. doi: 10.1073/pnas.1308701110. Epub 2013 Dec 16.

DOI:10.1073/pnas.1308701110
PMID:24344259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3890838/
Abstract

The rapid dissemination of the 2009 pandemic H1N1 influenza virus emphasizes the need for universal influenza vaccines that would broadly protect against multiple mutated strains. Recent efforts have focused on the highly conserved hemagglutinin (HA) stem domain, which must undergo a significant conformational change for effective viral infection. Although the production of isolated domains of multimeric ectodomain proteins has proven difficult, we report a method to rapidly produce the properly folded HA stem domain protein from influenza virus A/California/05/2009 (H1N1) by using Escherichia coli-based cell-free protein synthesis and a simple refolding protocol. The T4 bacteriophage fibritin foldon placed at the C terminus of the HA stem domain induces trimer formation. Placing emphasis on newly exposed protein surfaces, several hydrophobic residues were mutated, two polypeptide segments were deleted, and the number of disulfide bonds in each monomer was reduced from four to two. High pH and Brij 35 detergent emerged as the most beneficial factors for improving the refolding yield. To stabilize the trimer of the HA stem-foldon fusion, new intermolecular disulfide bonds were finally introduced between foldon monomers and between stem domain monomers. The correct immunogenic conformation of the stabilized HA stem domain trimer was confirmed by using antibodies CR6261, C179, and FI6 that block influenza infection by binding to the HA stem domain trimer. These results suggest great promise for a broadly protective vaccine and also demonstrate a unique approach for producing individual domains of complex multimeric proteins.

摘要

2009 年大流行性 H1N1 流感病毒的迅速传播强调了需要通用流感疫苗,以广泛预防多种突变株。最近的研究重点是高度保守的血凝素(HA)茎域,该区域必须发生重大构象变化才能有效感染病毒。尽管已经证明生产多聚体细胞外结构域蛋白的分离结构域具有一定难度,但我们报告了一种使用基于大肠杆菌的无细胞蛋白合成和简单复性方案,从流感病毒 A/加利福尼亚/05/2009(H1N1)快速生产正确折叠的 HA 茎域蛋白的方法。HA 茎域蛋白 C 末端的 T4 噬菌体纤维蛋白折叠结构域诱导三聚体形成。强调新暴露的蛋白质表面,突变了几个疏水性残基,删除了两个多肽片段,并将每个单体中的二硫键数量从四个减少到两个。高 pH 值和 Brij 35 去污剂是提高复性产率最有益的因素。为了稳定 HA 茎-折叠融合物的三聚体,最后在折叠结构域单体之间和茎域单体之间引入了新的分子间二硫键。通过使用 CR6261、C179 和 FI6 抗体证实了稳定的 HA 茎域三聚体的正确免疫原性构象,这些抗体通过与 HA 茎域三聚体结合来阻断流感感染。这些结果表明广泛保护性疫苗具有很大的前景,并且还展示了一种生产复杂多聚体蛋白的单个结构域的独特方法。

相似文献

1
Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.生产和稳定三聚体流感血凝素茎域,用于具有潜在广泛保护作用的流感疫苗。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30. doi: 10.1073/pnas.1308701110. Epub 2013 Dec 16.
2
Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens.无细胞生产三聚体流感血凝素头部结构域蛋白作为疫苗抗原。
Biotechnol Bioeng. 2012 Dec;109(12):2962-9. doi: 10.1002/bit.24581. Epub 2012 Aug 16.
3
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.完整 2009 年 H1N1 大流行流感病毒上 HA 三聚体的结构和可及性,以针对茎区域特异性中和抗体。
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4592-7. doi: 10.1073/pnas.1214913110. Epub 2013 Mar 4.
4
Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines.结构疫苗学:基于结构的设计针对流感 A 病毒血凝素亚型特异性亚单位疫苗。
Protein Cell. 2011 Dec;2(12):997-1005. doi: 10.1007/s13238-011-1134-y. Epub 2012 Jan 10.
5
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.H5N1 流感病毒血凝素的构象稳定性影响对广谱中和茎部抗体的敏感性。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
6
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.通过去除流感病毒血凝素蛋白的N-连接糖基化位点来揭示茎特异性中和表位用于疫苗设计
J Virol. 2016 Sep 12;90(19):8496-508. doi: 10.1128/JVI.00880-16. Print 2016 Oct 1.
7
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.与茎和三聚体界面具有广泛保护作用的抗体复合的流感嵌合血凝素结构。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2200821119. doi: 10.1073/pnas.2200821119. Epub 2022 May 20.
8
Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.血凝素亚基HA1和HA2中的单体间相互作用影响血凝素稳定性和流感病毒感染性。
J Virol. 2015 Oct;89(20):10602-11. doi: 10.1128/JVI.00939-15. Epub 2015 Aug 12.
9
Antibody recognition of a highly conserved influenza virus epitope.对高度保守的流感病毒表位的抗体识别。
Science. 2009 Apr 10;324(5924):246-51. doi: 10.1126/science.1171491. Epub 2009 Feb 26.
10
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.稳定的三聚体流感血凝素茎作为一种广泛保护性的免疫原。
Science. 2015 Sep 18;349(6254):1301-6. doi: 10.1126/science.aac7263. Epub 2015 Aug 24.

引用本文的文献

1
Rabies glycoprotein engineering for improved stability and expression.用于提高稳定性和表达的狂犬病糖蛋白工程
Vaccine. 2025 Jul 26;62:127541. doi: 10.1016/j.vaccine.2025.127541.
2
A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets.一种基于牛腺病毒载体的通用流感疫苗可在小鼠和雪貂中提供针对甲型和乙型流感病毒的保护。
Mol Ther Nucleic Acids. 2025 Jun 9;36(3):102594. doi: 10.1016/j.omtn.2025.102594. eCollection 2025 Sep 9.
3
Rational Design of a Foldon-Derived Heterotrimer Guided by Quantitative Native Mass Spectrometry.基于定量天然质谱的折叠子衍生异源三聚体的合理设计
J Am Chem Soc. 2025 Jul 9;147(27):23819-23826. doi: 10.1021/jacs.5c06094. Epub 2025 Jun 28.
4
Manipulation of immunodominant variable epitopes of norovirus capsid protein elicited cross-blocking antibodies to different GII.4 variants despite the low potency of the polyclonal sera.尽管多克隆血清效力较低,但对诺如病毒衣壳蛋白免疫显性可变表位的操作仍引发了针对不同GII.4变体的交叉阻断抗体。
J Virol. 2025 Jul 22;99(7):e0061125. doi: 10.1128/jvi.00611-25. Epub 2025 May 30.
5
M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy.展示M2e/NP双表位的纳米颗粒增强重组HA流感疫苗的交叉保护作用:一种通用的增强策略
Vaccines (Basel). 2025 Apr 15;13(4):412. doi: 10.3390/vaccines13040412.
6
Developing an -Based Cell-Free Protein Synthesis System for Artificial Spidroin Production and Characterization.开发一种用于人工蜘蛛丝蛋白生产和表征的基于-的无细胞蛋白质合成系统。 你提供的原文中“-Based”部分似乎不完整,存在信息缺失情况,可能会影响对整体内容的准确理解。
ACS Synth Biol. 2025 May 16;14(5):1829-1842. doi: 10.1021/acssynbio.5c00241. Epub 2025 Apr 21.
7
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses.表达带有自噬诱导肽的血凝素茎区的腺病毒载体疫苗赋予对1型和2型甲型流感病毒的交叉保护。
Vaccines (Basel). 2025 Jan 20;13(1):95. doi: 10.3390/vaccines13010095.
8
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.给予抗原性不同的流感病毒颗粒组合作为一种流感疫苗策略。
PLoS Pathog. 2025 Jan 22;21(1):e1012878. doi: 10.1371/journal.ppat.1012878. eCollection 2025 Jan.
9
Protein Expression Platforms and the Challenges of Viral Antigen Production.蛋白质表达平台与病毒抗原生产的挑战
Vaccines (Basel). 2024 Nov 28;12(12):1344. doi: 10.3390/vaccines12121344.
10
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem.调节靶向流感血凝素茎部的免疫球蛋白种系编码结构基序的免疫显性等级。
Cell Rep. 2024 Dec 24;43(12):114990. doi: 10.1016/j.celrep.2024.114990. Epub 2024 Nov 22.

本文引用的文献

1
Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults.重组三价流感疫苗(Flublok(®)):在成人季节性流感预防中的应用综述。
Drugs. 2013 Aug;73(12):1357-66. doi: 10.1007/s40265-013-0103-6.
2
Escherichia coli-based cell free production of flagellin and ordered flagellin display on virus-like particles.基于大肠杆菌的无细胞体系生产鞭毛蛋白和病毒样颗粒上的有序鞭毛蛋白展示。
Biotechnol Bioeng. 2013 Aug;110(8):2073-85. doi: 10.1002/bit.24903. Epub 2013 May 1.
3
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.完整 2009 年 H1N1 大流行流感病毒上 HA 三聚体的结构和可及性,以针对茎区域特异性中和抗体。
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4592-7. doi: 10.1073/pnas.1214913110. Epub 2013 Mar 4.
4
Broadly neutralizing antiviral antibodies.广谱中和抗病毒抗体。
Annu Rev Immunol. 2013;31:705-42. doi: 10.1146/annurev-immunol-032712-095916. Epub 2013 Jan 16.
5
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.大流行性 H1N1 流感疫苗在人体内诱导出一种有利于广泛交叉反应性记忆 B 细胞的回忆反应。
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52. doi: 10.1073/pnas.1118979109. Epub 2012 May 21.
6
Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.在可扩展的体外转录-翻译系统中产生的无糖基化抗体和抗体片段。
MAbs. 2012 Mar-Apr;4(2):217-25. doi: 10.4161/mabs.4.2.19202. Epub 2012 Mar 1.
7
Cell-free protein synthesis: applications come of age.无细胞蛋白质合成:应用走向成熟。
Biotechnol Adv. 2012 Sep-Oct;30(5):1185-94. doi: 10.1016/j.biotechadv.2011.09.016. Epub 2011 Oct 8.
8
Cell-based flu vaccines ready for US prime time.基于细胞的流感疫苗准备在美国迎来黄金时期。
Nat Rev Drug Discov. 2011 Apr;10(4):246. doi: 10.1038/nrd3414.
9
Microscale to manufacturing scale-up of cell-free cytokine production--a new approach for shortening protein production development timelines.无细胞细胞因子生产的从微尺度到制造规模的放大——一种缩短蛋白质生产开发时间的新方法。
Biotechnol Bioeng. 2011 Jul;108(7):1570-8. doi: 10.1002/bit.23103. Epub 2011 Mar 31.
10
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.接种流感病毒血凝素的合成肽可提供针对不同病毒亚型的保护。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18979-84. doi: 10.1073/pnas.1013387107. Epub 2010 Oct 18.